These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3033748)

  • 1. Depression and excitation induced in mice by two geometric isomers of (+)13,14-didehydro-20-methyl-carboprostacyclin, FCE 22177 and FCE 22176. Comparison with effects on blood pressure and platelet aggregation.
    Caparrotta L; Ceserani R; Mongelli N; Santi-Soncin E; Ragazzi E; Fassina G
    Prostaglandins; 1987 Mar; 33(3):351-62. PubMed ID: 3033748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative study of PGI2 and two analogues (FCE 21292 and FCE 21258) in vitro and in vivo.
    Morley J; Page CP; Paul W; Mongelli N; Ceserani R; Gandolfi C
    Prostaglandins Leukot Med; 1983 Aug; 11(4):391-9. PubMed ID: 6353424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological evaluation of 5-(Z,E)-13,14-didehydro-20-methyl-carboprostacyclin (FCE 22509).
    Ceserani R; Grossoni M; Ukmar G; Colombo M; Mongelli N
    Prostaglandins Leukot Med; 1986 Mar; 21(3):231-45. PubMed ID: 3517883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of platelet aggregation by a new agent, 5-(Z,E)-13,14-didehydro-20-methyl-carbo PGI2 (FCE 22509).
    Bergamaschi M; Pierucci L; Ferti C; Corsi G; Branzoli U; Mandelli V
    Prostaglandins Leukot Med; 1984 Oct; 16(1):19-27. PubMed ID: 6393142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. (5Z)-carbacyclin displays agonist-antagonist properties on prostacyclin-receptors in platelets and vascular myocytes.
    Corsini A; Oliva D; Folco GC; Giovanazzi S; Noe' MA; Fumagalli R; Nicosia S
    Biomed Biochim Acta; 1988; 47(10-11):S104-7. PubMed ID: 3073757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Further studies with 5E and 5Z analogues of PGI2 in platelets and vasculature.
    Oliva D; Giovanazzi S; Lograno M; Mongelli N; Corsini A; Fumagalli R; Nicosia S
    Adv Prostaglandin Thromboxane Leukot Res; 1989; 19():172-5. PubMed ID: 2526466
    [No Abstract]   [Full Text] [Related]  

  • 7. Platelet and other effects of carboprostacyclin--a stable prostacyclin analogue.
    Adaikan PG; Karim SM; Lau LC
    Prostaglandins Med; 1980 Oct; 5(4):307-20. PubMed ID: 7003626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. (5Z)-carbacyclin discriminates between prostacyclin-receptors coupled to adenylate cyclase in vascular smooth muscle and platelets.
    Corsini A; Folco GC; Fumagalli R; Nicosia S; Noe MA; Oliva D
    Br J Pharmacol; 1987 Jan; 90(1):255-61. PubMed ID: 3545351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostaglandin endoperoxide analogues which are both thromboxane receptor antagonists and prostacyclin mimetics.
    Armstrong RA; Jones RL; MacDermot J; Wilson NH
    Br J Pharmacol; 1986 Mar; 87(3):543-51. PubMed ID: 3026540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on antiplatelet effects of OP-41483, a prostaglandin I2 analog, in experimental animals. II. Mechanism of its antiplatelet effect.
    Fujitani B; Wakitani K
    Jpn J Pharmacol; 1990 May; 53(1):25-33. PubMed ID: 2161965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cardiovascular and platelet actions of 9 beta-methyl carbacyclin (ciprostene), a chemically stable analogue of prostacyclin, in the dog and monkey.
    Allan G; Follenfant MJ; Lidbury P; Oliver PL; Whittle BJ
    Br J Pharmacol; 1985 Jun; 85(2):547-55. PubMed ID: 3896365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Action of carbacyclic 13,14-didehydro-analogs of prostacyclin on the contractile activity of the rat stomach muscles].
    Kobzar' GT; Lopp MI; Lille IuE
    Farmakol Toksikol; 1989; 52(3):38-40. PubMed ID: 2507349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A chemically stable analogue, 9 beta-methyl carbacyclin, with similar effects to epoprostenol (prostacyclin, PGI2) in man.
    O'Grady J; Hedges A; Whittle BJ; Al-Sinawi LA; Mekki QA; Burke C; Moody SG; Moti MJ; Hassan S
    Br J Clin Pharmacol; 1984 Dec; 18(6):921-33. PubMed ID: 6085004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of the antiaggregatory activity of prostacyclin by propranolol in human platelets.
    Callahan KS; Johnson AR; Campbell WB
    Circulation; 1985 Jun; 71(6):1237-46. PubMed ID: 2986877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of heparin on platelet aggregation inhibited by PGI2, trifluoperazine and verapamil.
    Weber DR; Nichols WK; Mohammad SF
    Thromb Res; 1986 May; 42(4):477-87. PubMed ID: 3012821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostacyclin-lipoprotein interactions. Studies on human platelet aggregation and adenylate cyclase.
    Colli S; Maderna P; Tremoli E; Baraldi A; Rovati GE; Gianfranceschi G; Nicosia S
    Biochem Pharmacol; 1985 Jul; 34(14):2451-7. PubMed ID: 3893439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cardiovascular and platelet effects of epoprostenol (prostacyclin, PGI2) are unaffected by beta-adrenoceptor blockade in man.
    Hassan S; Pickles H; Fish A; Burke C; Warrington S; O'Grady J
    Br J Clin Pharmacol; 1982 Sep; 14(3):369-77. PubMed ID: 6127095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Azelastine potentiates the prostaglandin-induced increase of cyclic AMP content in human platelets and in guinea-pig alveolar macrophages.
    Hatmi M; Havet N; Vargaftig BB; Bachelet M
    Prostaglandins; 1992 May; 43(5):457-72. PubMed ID: 1374922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonprostanoid prostacyclin mimetics. 4. Derivatives of 2-[3-[2-(4,5-diphenyl-2-oxazolyl)ethyl]phenoxy]acetic acid substituted alpha to the oxazole ring.
    Meanwell NA; Rosenfeld MJ; Wright JJ; Brassard CL; Buchanan JO; Federici ME; Fleming JS; Gamberdella M; Hartl KS; Zavoico GB
    J Med Chem; 1993 Nov; 36(24):3871-83. PubMed ID: 8254619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo interaction of prostacyclin with an inhibitor of cyclic nucleotide phosphodiesterase, HL 725.
    Darius H; Lefer AM; Leprán I; Smith JB
    Br J Pharmacol; 1985 Mar; 84(3):735-41. PubMed ID: 2985163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.